181 related articles for article (PubMed ID: 29376868)
21. Na+-NQR (Na+-translocating NADH:ubiquinone oxidoreductase) as a novel target for antibiotics.
Dibrov P; Dibrov E; Pierce GN
FEMS Microbiol Rev; 2017 Sep; 41(5):653-671. PubMed ID: 28961953
[TBL] [Abstract][Full Text] [Related]
22. Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias.
Westfall S; Dinh DM; Pasinetti GM
J Alzheimers Dis; 2020; 75(2):559-570. PubMed ID: 32310171
[TBL] [Abstract][Full Text] [Related]
23. The role of gut microbiota in pathogenesis of Alzheimer's disease.
Bostanciklioğlu M
J Appl Microbiol; 2019 Oct; 127(4):954-967. PubMed ID: 30920075
[TBL] [Abstract][Full Text] [Related]
24. Correlation between APOE4 gene and gut microbiota in Alzheimer's disease.
Chen XX; Zeng MX; Cai D; Zhou HH; Wang YJ; Liu Z
Benef Microbes; 2023 Sep; 14(4):349-360. PubMed ID: 38661357
[TBL] [Abstract][Full Text] [Related]
25. A metagenomic study of the gut microbiome in Behcet's disease.
Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
[TBL] [Abstract][Full Text] [Related]
26. Characterizing the gut microbiome changes with aging in a novel Alzheimer's disease rat model.
Nagarajan A; Srivastava H; Morrow CD; Sun LY
Aging (Albany NY); 2023 Jan; 15(2):459-471. PubMed ID: 36640271
[TBL] [Abstract][Full Text] [Related]
27. Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer's disease.
Fujii Y; Nguyen TTT; Fujimura Y; Kameya N; Nakamura S; Arakawa K; Morita H
Biosci Biotechnol Biochem; 2019 Nov; 83(11):2144-2152. PubMed ID: 31327302
[TBL] [Abstract][Full Text] [Related]
28. Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan.
Bäuerl C; Collado MC; Diaz Cuevas A; Viña J; Pérez Martínez G
Lett Appl Microbiol; 2018 Jun; 66(6):464-471. PubMed ID: 29575030
[TBL] [Abstract][Full Text] [Related]
29. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiome alterations in Alzheimer's disease.
Vogt NM; Kerby RL; Dill-McFarland KA; Harding SJ; Merluzzi AP; Johnson SC; Carlsson CM; Asthana S; Zetterberg H; Blennow K; Bendlin BB; Rey FE
Sci Rep; 2017 Oct; 7(1):13537. PubMed ID: 29051531
[TBL] [Abstract][Full Text] [Related]
31. Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.
Lin L; Zheng LJ; Zhang LJ
Mol Neurobiol; 2018 Nov; 55(11):8243-8250. PubMed ID: 29524051
[TBL] [Abstract][Full Text] [Related]
32. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
33. Intestinal Microflora Changes in Patients with Mild Alzheimer's Disease in a Chinese Cohort.
Wang Y; Li L; Zhao X; Sui S; Wang Q; Shi G; Xu H; Zhang X; He Y; Gu J
J Alzheimers Dis; 2022; 88(2):563-575. PubMed ID: 35662119
[TBL] [Abstract][Full Text] [Related]
34. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
35. Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
Brandscheid C; Schuck F; Reinhardt S; Schäfer KH; Pietrzik CU; Grimm M; Hartmann T; Schwiertz A; Endres K
J Alzheimers Dis; 2017; 56(2):775-788. PubMed ID: 28035935
[TBL] [Abstract][Full Text] [Related]
36. "Muscle-Gut-Brain Axis": Can Physical Activity Help Patients with Alzheimer's Disease Due to Microbiome Modulation?
Schlegel P; Novotny M; Klimova B; Valis M
J Alzheimers Dis; 2019; 71(3):861-878. PubMed ID: 31476155
[TBL] [Abstract][Full Text] [Related]
37. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease.
Köhler CA; Maes M; Slyepchenko A; Berk M; Solmi M; Lanctôt KL; Carvalho AF
Curr Pharm Des; 2016; 22(40):6152-6166. PubMed ID: 27604604
[TBL] [Abstract][Full Text] [Related]
38. Associations Between Gut Microbiota and Alzheimer's Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives.
Shen L; Ji HF
J Alzheimers Dis; 2019; 68(1):25-31. PubMed ID: 30814354
[TBL] [Abstract][Full Text] [Related]
39. Uncovering the trimethylamine-producing bacteria of the human gut microbiota.
Rath S; Heidrich B; Pieper DH; Vital M
Microbiome; 2017 May; 5(1):54. PubMed ID: 28506279
[TBL] [Abstract][Full Text] [Related]
40. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
